艰难的闭膜炎和结直肠癌:一个危险的联系
Gabrio Bassotti1,2, Fabrizio Stracci3, Pierfrancesco Marconi4
1Gastroenterology, Hepatology & Digestive Endoscopy Section, Department of Medicine and Surgery, University of Perugia.
European journal of gastroenterology & hepatology
|July 28, 2023
概括
抗生素的使用可能会导致肠道失调,增加Clostridioides difficile感染的风险. 新出现的证据表明,Clostridioides difficile也可能是潜在的致癌物,有助于结直肠癌的发展.
科学领域:
- 胃肠道学和微生物学
- 在瘤学瘤学.
背景情况:
- 结肠直肠疾病涉及复杂的相互作用,包括肠道微生物群.
- 过度使用抗生素是肠道失调和Clostridioides difficile感染 (CDI) 的主要驱动因素.
- CDI可以导致严重的疾病,如传染性腹,伪膜性结肠炎和有毒的大结肠,经常复发.
研究的目的:
- 分析Clostridioides difficile作为结直肠癌 (CRC) 的致癌物质的潜在作用.
- 探索肠道失调症,CDI和CRC发育之间的联系.
主要方法:
- 审查最近的实验证据.
- 对结直肠疾病中的病理生理因素的分析.
- 研究Clostridioides difficile的致病机制和毒素 (A和B).
主要成果:
- 克洛斯特里迪奥伊德困难感染与肠道失生症密切相关.
- 细菌的毒素 (A和B) 导致严重的胃肠道病理.
- 实验数据表明,Clostridioides difficile和结直肠癌之间存在潜在的联系.
结论:
- 困难菌,像其他细菌一样,需要作为结肠直肠癌的潜在致癌物质进行调查.
- 了解肠道微生物群在CRC中的作用至关重要.
- 需要进一步的研究来证实Clostridioides difficile.的致癌潜力.
更多相关视频
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
219
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
219
Inflammatory Bowel Disease II: Crohn's Disease
296
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
296
Drugs for Treatment of Ulcerative Colitis in IBD
175
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
175
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
158
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
158
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195


